האגודה למלחמה בסרטן - במה - גיליון מס' 23 - מאי 2020

ביטאון לעובדי בריאות בנושא מחלת הסרטן והשלכותיה במה

8. Morton DL, Thompson JF, Cochran AJ, et al. Final trial report of sentinel lymph node biopsy versus observation in melanoma. N Engl J Med. 2014 Feb 13;370(7):599-609. 9. LeiterU, Stadler R, Mauch C, et al. Complete lymph node dissection versus no dissection in patients with sentinel lymph node positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial. Lancet Oncol. 2016 Jun;17(6):757-67. Epub 2016 May 5. 10. Faries MB, Thompson JF, Cochran AJ, et al. Completion dissection or observation for sentinel node metastasis in melanoma. N Eng J Med. 2017 Jun 8;376(23):2211-2222. 11. Bamboat ZM, Konstantinidis IT, Kuk D, et al. Observation after a positive sentinel lymph node biopsy in patients with melanoma. Ann Surg Oncol. 2014 Sep;21(9):3117 - 23. Epub 2014 May 16. 12. Eggermont AM, Chiarion-Sileni V, Grob JJ, et al. Prolonged survival in stage III melanoma with ipilimumab adjuvant therapy. N Engl J Med. 2016 Nov 10;375(19):1845-55. Epub 2016 Oct 7. 13. Eggermont AMM, Blank CU, Mandala M, et al. Adjuvant pembrolizumab versus placebo in resected stage III melanoma. N Engl J Med. 2018 May 10;378(19):1789-801. Epub 2018 Apr 15. 14. Long GV, Hauschild A, Santinami N, et al. Adjuvant dabrafenib plus trametinib in stage III BRAF-mutated melanoma. N Engl J Med. 2017 Nov 9;377(19):1813-23. Epub 2017 Sep 10. 15. National Comprehensive Cancer Network. NCCN Clinical Guidelines in Oncology: Cutaneous Melanoma. Version 2.2019. Available from https://www.nccn.org [Version 2.2019 - March 12, 2019].

42